Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2007
12/05/2007EP1861376A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
12/05/2007EP1861365A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
12/05/2007EP1860942A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/05/2007EP1658288B1 2-amino-5-benzoylthiazole npy antagonists
12/05/2007EP1433479B1 Appetite-stimulating agents and remedies for anorexia
12/05/2007EP1208085B1 Benzanilides as potassium channel openers
12/05/2007EP1169294B1 Pharmaceutical compounds
12/05/2007CN101084195A 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
12/05/2007CN101084189A Indol derivatives as inhibitors of soluble adenylyl cyclase
12/05/2007CN101083989A Use of thiazolidinone derivatives as antiangiogenic agents
12/05/2007CN101083988A 有丝分裂驱动蛋白抑制剂及其使用方法 Mitotic kinesin inhibitors and methods of use
12/05/2007CN101081843A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
12/05/2007CN100352817C Pyridinoylpiperidines as 5-HTLF agonists
12/05/2007CN100352808C Heterocyclic diamide invertebrate pest control agents
12/05/2007CN100352807C Chemical compounds
12/04/2007US7304160 intermediates for enantiomerically pure analogs having silyl or alkyl groups at C4 position; organometallic nucleophile or Grignard and an silyl or alkyl acyl halide reacted with nicotine; oxidation and deacylation to 4-hydroxy; modulate nicotinic acetylcholine receptors; Alzheimer's, Parkinson's
12/04/2007US7304087 1-acyl-pyrrolidine derivatives for the treatment of viral infections
12/04/2007US7304086 Inhibitors of glutaminyl cyclase
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304079 Preparing 3-benzothiazolylalkyl-1-indolylacetic acids and esters by cyclizing a 3-(anilinothiocarbonylalkyl)-1-indolylacetic ester with potassium ferricyanide or sodium hydride, optionally deprotecting the acid group; aldose reductase inhibitors for diabetic complications; side effect reduction
12/04/2007US7304078 Thrombosis; cardiovascular disorders; restenosis; hypotensive agents; antiarrhythmia agents; antiinflamamtroy agents; central nervous system disorders
12/04/2007US7304077 Asthma, rhinitis therapy
12/04/2007US7304063 Inhibitors of Akt activity
12/04/2007US7304062 Peroxisome proliferator activated receptor alpha agonists
12/04/2007US7304061 4-(5-Methyl-2-phenyl-pyrimidin-4-yl)-1H-pyrrole-2 carboxylic acid (2-hydroxy-1-(S)-phenyl-ethyl)-amide; Mitogen-activated protein kinase inhibitor; anticarcinogenic, antiinflammatory agent,neurodegenerative disorders, restenosis, antidiabetic, antiallergen, and cardiovascular disease
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304058 For therapy of Alzheimer's disease, depression
12/04/2007US7304057 Substituted 6-membered N-heterocyclic compounds and method for their use as neurological regulator
12/04/2007US7304052 Irritable bowel syndrome; gastrointestinal disorders
12/04/2007CA2424964C Nitrogen-containing 5-membered ring compound
12/04/2007CA2280753C 1,4-substituted cyclic amine derivatives
11/2007
11/29/2007WO2007136703A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/29/2007WO2007136574A2 Medical devices having polymeric regions based on vinyl ether block copolymers
11/29/2007WO2007136573A2 Antidiabetic bicyclic compounds
11/29/2007WO2007136572A2 Antidiabetic bicyclic compounds
11/29/2007WO2007134827A1 5-phenyl-thiaz0l-2-yl-urea derivatives and use as pi3 kinase inhibitors
11/29/2007WO2007134799A1 Novel microbiocides
11/29/2007WO2007134625A1 New benzothiazinone derivatives and their use as antibacterial agents
11/29/2007WO2007134457A1 Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/29/2007WO2007090749A3 Benzamide and heteroarene derivatives as cetp inhibitors
11/29/2007WO2007084413A3 Methods for treating hepatitis c
11/29/2007WO2007075895A3 Heterocyclic derivatives as modulators of ion channels
11/29/2007WO2007057407A3 Insecticidal methods using 3-amino-1,2-benzisothiazole derivatives
11/29/2007WO2007045893A3 Beta adrenergic receptor pharmacophore
11/29/2007WO2007017144A3 Macrocylic inhibitors of hepatitis c virus
11/29/2007WO2007014927A3 Macrocyclic inhibitors of hepatitis c virus
11/29/2007WO2007006594A3 Reactive azo dyes, methods for the production thereof and their use
11/29/2007WO2006128659A3 Piperazine derivative renin inhibitors.
11/29/2007US20070276147 Synthesis of Oligomeric Epicatechin- and Catechin-Derived Procyanidins
11/29/2007US20070276017 Thiadiazoline Derivative
11/29/2007US20070276016 Cholecystokinin (CCK2) receptor modulators; e.g. 2-(Benzo[1,2,5]thiadiazole-4sulfonylamino)-4-fluoro-N-[1-(4-fluoro-phenyl)-ethyl]-N-methyl-benzamide; pancreatic adenocarcinoma, pain, eating disorders, gastro-esophageal reflux disease, ulcers, anxiety
11/29/2007US20070276012 Process for Preparing Thiazolidinediones
11/29/2007US20070276011 Plasminogen Activator Inhibitor-1 Inhibitor
11/29/2007US20070276009 Compositions and Methods for Viral Inhibition
11/29/2007US20070275988 Transition state structure and inhibitors of thymidine phosphorylases
11/29/2007US20070275960 Phenyl and pyridyl compounds for inflammation and immune-related uses
11/29/2007US20070275952 Tie-2 Modulators and Methods of Use
11/29/2007US20070275911 Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
11/29/2007CA2652841A1 New benzothiazinone derivatives and their use as antibacterial agents
11/29/2007CA2651700A1 Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/29/2007CA2651153A1 Antidiabetic bicyclic compounds
11/29/2007CA2650795A1 Novel microbiocides
11/29/2007CA2650655A1 5-phenyl-thiaz0l-2-yl-urea derivatives and use as pi3 kinase inhibitors
11/29/2007CA2649913A1 N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/28/2007EP1860106A1 Tricyclic thrombin receptor antagonists
11/28/2007EP1859798A1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
11/28/2007EP1858901A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/28/2007EP1858893A1 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents
11/28/2007EP1858892A1 Anhydrous ziprasidone mesylate and a process for its preparation
11/28/2007EP1858891A2 Crystalline forms of ziprasidone mesylate
11/28/2007EP1858888A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/28/2007EP1858885A1 Indolylamino quinazoline derivatives as antitumor agents
11/28/2007EP1858884A1 Indazolylamino quinazoline derivatives as antitumor agents
11/28/2007EP1858883A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/28/2007EP1858862A1 PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS
11/28/2007EP1858857A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
11/28/2007EP1858854A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists
11/28/2007EP1761516B1 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi
11/28/2007EP1725543B1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1006794B1 A method for treating or preventing alzheimer's disease
11/28/2007CN101077868A Thiadiazoles substituted imidazoles anti-anaerobe compounds
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/28/2007CN100351230C Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester
11/27/2007US7301037 Charged compounds comprising a nucleic acid binding moiety and uses therefor
11/27/2007US7300950 Pyrazole derivatives, their preparation and their use in pharmaceuticals
11/27/2007US7300946 For use in controlling insects; controlling tobacco budworm
11/27/2007US7300945 For therapy of of certain central nervous system (CNS) diseases, anxiety, depression, a sleep disorder, schizophrenia, or attention deficit-hyperactivity disorder
11/27/2007US7300941 Non-imidazole compounds
11/27/2007US7300939 For therapy of neuropathic pain
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/27/2007US7300928 Benzimidazolidinone derivatives as muscarinic agents
11/27/2007US7300927 Method for treating or preventing Alzheimer's disease
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/22/2007WO2007134169A2 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
11/22/2007WO2007134085A2 Isothiazolidines useful in the treatment of ocular hypertensive conditions
11/22/2007WO2007133622A2 Selective inhibitors of rock protein kinase and uses thereof
1 ... 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 ... 628